Evaluation of obsessive-compulsive disorder in cancer patients: A case-control study [0.03%]
癌症患者中强迫症的评定：一项病例对照研究
Fatih İnci,Habibe İnci
Fatih İnci
Background: This study was aimed to investigate the frequency of obsessive-compulsive disorder, which is known to cause depression in cancer patients and may result in cancer treatment failure. ...
Pilot study on inguinofemoral lymphadenectomy by sealing device - Ilsede study [0.03%]
使用闭合装置进行股沟淋巴结清扫的初步研究-Ilsede 研究
Ignacio Beamonte,Myriam Gracia,Jaime Siegrist et al.
Ignacio Beamonte et al.
Objective: Our objective was to evaluate the impact of the use of a sealing device during inguinofemoral lymphadenectomy on the reduction of postoperative complications. ...
Expression of the long noncoding RNA CASC2 in acute myeloid leukemia and its prognostic significance [0.03%]
长链非编码RNA CASC2在急性髓系白血病中的表达及其预后意义
Sida Peng,Qingqing Yang,Yuhang Pan et al.
Sida Peng et al.
Background: Cancer susceptibility candidate 2 (CASC2) was found underexpressed in multiple types of human malignancies. However, the specific role of CASC2 in AML remains uncertain. The purpose of this study is to explore...
Frequency and clinical significance of human papilloma virus in oral cancer - A study from Kerala [0.03%]
口腔癌中人乳头瘤病毒的频率和临床意义-来自喀拉拉邦的研究
Divya Raj,Preethi Sara George,S Lakshmi et al.
Divya Raj et al.
Background: Oral cancer is a major health problem in India. Recently an increase in the oral cancer incidence among young individuals without any habits was observed, which may be due to Human Papilloma Virus (HPV). Howev...
Perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcome [0.03%]
胃癌的围手术期5-氟尿嘧啶、亚叶酸钙、奥沙利铂和多西他赛(FLOT)方案：病理反应等级及其与临床结果的关系
Muhammed M Atci,Saban Secmeler,Abdullah Sakin et al.
Muhammed M Atci et al.
Background: We aimed to evaluate the data of perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy regimen in locally advanced gastric cancer (LAGC) patients with real-life experience. ...
Short-term efficacy and safety of camrelizumab-based treatment in refractory or metastatic esophageal squamous cell carcinoma [0.03%]
卡瑞利珠单抗用于治疗复发或转移性食管鳞状细胞癌的短期有效性和安全性研究
Yuan Yuan,Qingliang Meng,Xiaowu Li et al.
Yuan Yuan et al.
Background: The aim of this study was to evaluate the short-term efficacy and safety of camrelizumab in combination with apatinib in the treatment of refractory or metastatic esophageal squamous cell carcinoma (ESCC). ...
Safety of Endostar in combination with chemotherapy in patients with cancer [0.03%]
恩度与癌症化疗药物联用的安全性研究
Dong-Xiao Wang,Man Zhu,Dai-Hong Guo et al.
Dong-Xiao Wang et al.
Background: Several studies have indicated the benefits and safety of Endostar in combination with chemotherapy, but the exact real-life safety of Endostar is poorly known. This study aimed to assess the safety of Endosta...
A novel oncoplastic technique for centrally located breast cancers: An experience from a Tertiary care center in North India [0.03%]
用于中央型乳腺癌的一种新型肿瘤整形技术：来自北印度一家三级护理中心的体验
Vikas Sharma,Sandhya Pandey,Gaurav Gupta et al.
Vikas Sharma et al.
Context: Oncoplastic breast surgery is the current standard for treatment of early breast cancer, offering a balance between good cosmetic outcomes and limited risk of locoregional recurrence. Still, the best technique of...
Myeloid sarcoma of the small intestine in nonleukemic patients - A report of three cases with review of literature [0.03%]
非白血病患者小肠粒细胞肉瘤——三例病例报告及文献复习
Bipin S Thingujam,Anil Irom,Babina Thangjam et al.
Bipin S Thingujam et al.
Background: Granulocytic sarcoma (GS) or myeloid sarcoma (MS) is a tumor of hematopoietic stem cell origin composed of myeloblasts or immature myeloid cells presenting as tumor masses in an extramedullary site. The tumor ...
Indian experience of Afatinib for EGFR mutation-positive advanced lung adenocarcinoma a real-world retrospective study [0.03%]
阿法替尼治疗EGFR突变阳性晚期肺腺癌的印度经验：一项真实世界的回顾性研究
Ullas Batra,Mansi Sharma,Parveen Jain et al.
Ullas Batra et al.
Introduction: Afatinib, a second-generation EGFR TKI, was approved in 2015 for the treatment of metastatic NSCLC in India. We aimed to evaluate the clinical outcomes of Afatinib therapy in a real-world setting. ...